By targeting cell surface receptors such as EGFR, VEGFR, HER2, and MET, and their downstream signaling pathways, it is possible to inhibit HNSCC cell proliferation, invasion, and migration. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.